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Recent studies indicate that membrane vesicles (MVs)
secreted by various cells are associated with human diseases,
including arthritis, atherosclerosis, cancer, and chronic kidney
disease. The possibility that MVs may induce the formation of
mineralo-organic nanoparticles (NPs) and ectopic calcification
has not been investigated so far. Here, we isolated MVs ranging
in size between 20 and 400 nm from human serum and FBS
using ultracentrifugation and sucrose gradient centrifugation.
The MV preparations consisted of phospholipid-bound vesicles
containing the serum proteins albumin, fetuin-A, and apolipoprotein A1; the mineralization-associated enzyme alkaline
phosphatase; and the exosome proteins TNFR1 and CD63.
Notably, we observed that MVs induced mineral precipitation
following inoculation and incubation in cell culture medium.
The mineral precipitates consisted of round, mineralo-organic
NPs containing carbonate hydroxyapatite, similar to previous
descriptions of the so-called nanobacteria. Annexin V-immunogold staining revealed that the calcium-binding lipid phosphatidylserine (PS) was exposed on the external surface of serum
MVs. Treatment of MVs with an anti-PS antibody significantly
decreased their mineral seeding activity, suggesting that PS may
provide nucleating sites for calcium phosphate deposition on
the vesicles. These results indicate that MVs may represent
nucleating agents that induce the formation of mineral NPs in
body fluids. Given that mineralo-organic NPs represent precursors of calcification in vivo, our results suggest that MVs may
initiate ectopic calcification in the human body.
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Recent studies indicate that various NPs3 present in the environment constantly interact with the human body and may be
associated with disease conditions. For instance, the inhalation
of asbestos nanofibers derived from fireproof materials is associated with the development of lung cancer and fibrotic lung
damage known as asbestosis (1). Similarly, titanium dioxide
NPs, which are widely used as whitening agents in commercial
products, induce acute toxicity to various organs in laboratory
animals (2). Given that NPs show unexpected size-dependent
properties and increased access to various body compartments,
the potential toxicity of such nanomaterials represents an
important safety concern and is now a major research focus in
the fields of nanomedicine and nanotoxicology (3).
Mineralized NPs called NB were initially described as the
smallest living microorganisms on earth (4) and as the possible
causative agent of various human diseases, including Alzheimer
disease, atherosclerosis, cancer, chronic kidney disease, kidney
stones, and prostatitis (5–7). However, recent studies performed by us (8 –17) and others (18 –22) have shown that the
so-called NB actually represent non-living mineralo-organic
NPs that possess biomimetic properties, including the ability to
increase in size and number in culture. Although the hypothesis
that NB represent living microorganisms has been discarded,
several studies have indicated that mineral NPs similar to NB
do form in the growing bones and teeth of vertebrates (23–25).
Mineralo-organic NPs have also been observed in undesired,
ectopic calcification associated with various human and animal
conditions (26 –30). As such, these mineral NPs may represent
calcification precursors found in both physiological and pathological mineralization processes.

3

The abbreviations used are: NP, nanoparticle; ALP, alkaline phosphatase;
apoA-I, apolipoprotein AI; CPP, calciprotein particle; DiR, 1,1⬘-dioctadecyl3,3,3⬘,3⬘-tetramethylindotricarbocyanine iodide; EDX, energy-dispersive
x-ray; HAP, hydroxyapatite; HS, human serum; MV, membrane vesicle; NB,
nanobacteria; PS, phosphatidylserine; TEM, transmission electron microscopy; VSMC, vascular smooth muscle cell.
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Background: Membrane vesicles (MVs) released from various cells are associated with human diseases.
Results: MVs isolated from human serum induce the formation of mineralo-organic nanoparticles in culture.
Conclusion: MVs represent a nucleating factor that promotes the formation of mineralo-organic nanoparticles and the precipitation of mineral deposits in body fluids.
Significance: The ectopic precipitation of carbonate apatite deposits in body fluids and tissues may be initiated in part by MVs.
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ditions. Raoult et al. (22) speculated that fetuin-A, a systemic
calcification inhibitor (45, 46) associated with NB (9, 22), may
initially inhibit NB formation but eventually act as a nucleator
of NB formation following a conformational change similar to
prion conversion. Our own experiments have shown that
serum proteins like albumin and fetuin-A fail to induce NB
formation under the conditions tested, although these proteins
may form seeds for the formation of mineralo-organic NPs
once the concentrations of calcium and phosphate ions exceed
saturation (11). These results suggest that other molecules or
structures, possibly in the form of lipid membranes, may represent factors that induce the formation of mineralo-organic
NPs similar to the so-called NB in body fluids.
In the present study, we examined the possibility that mineral NP formation may be induced by MVs present in body
fluids. We isolated a population of MVs from human serum
(HS) and FBS and characterized the morphological and biochemical composition of these particles. Our results show that
the isolated serum MVs induce the formation of mineraloorganic NPs when inoculated and incubated in cell culture
medium, suggesting that MVs may serve as a nucleating agent
of mineral NPs in culture and as a factor that induces ectopic
calcification in human body fluids.

MATERIALS AND METHODS
Isolation of Membrane Vesicles—Blood was collected from
healthy human volunteers using a conventional venipuncture
method. Written informed consents were obtained from the
volunteers, and the use of human samples was approved by the
Institutional Review Board of Chang Gung Memorial Hospital
(Linkou, Taiwan). Whole blood was collected into Vacutainer
tubes without anticoagulant (BD Biosciences). After centrifugation at 1,500 ⫻ g for 15 min at room temperature, the supernatant corresponding to HS was collected and stored at ⫺20 °C.
HS and commercial FBS (Biological Industries) were filtered
through 0.2-m pore membranes prior to use.
MVs were isolated as before (47, 48), with minor modifications. Briefly, 10 ml of HS and FBS was centrifuged at 800 ⫻ g
for 15 min at 4 °C to spin down and remove large cell debris.
The resulting supernatant was centrifuged for 30 min at
10,000 ⫻ g. The supernatant obtained this way was centrifuged
for 60 min at 15,000 ⫻ g (SW27 rotor, Beckman Instruments).
Material present in the supernatant was pelleted by ultracentrifugation at 200,000 ⫻ g for 2 h at 4 °C (SW41 rotor, Beckman
Instruments). The pellet was suspended in 1 ml of HEPES
buffer (20 mM HEPES, 140 mM NaCl, pH 7.4) and is referred in
the present study as “membrane vesicles” (MVs). In some
experiments, sodium azide was added at 0.02% to prevent
microbial contamination.
Dynamic Light Scattering—One ml of resuspended MVs was
transferred to disposable plastic cuvettes (Kartell) and mixed by
gentle inversion prior to reading using a Delsa Nano Submicron
Particle Analyzer (Beckman Coulter). Measurements were performed at room temperature at an incident angle of 165°.
Although the relative particle unit used in the y axis of Fig. 1, A
and B, represents arbitrary values, this unit correlates in a linear
manner with the observed particle amount under the conditions used.
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Downloaded from http://www.jbc.org/ at Univ of the Pacific on April 17, 2017

Human body fluids have been shown to contain membrane
vesicles (MVs) in the form of small lipid-bound vesicles
released from various cells (31). These vesicles have been
broadly categorized as exosomes, microvesicles, and apoptotic
bodies (32). Exosomes represent 30 –100-nm vesicles released
from cellular endosomes and are thought to be involved in cellto-cell signaling (32–34). Microvesicles are a more heterogeneous group of 100 –1,000 nm vesicles released from the plasma
membrane of various cells; they have been implicated in intercellular communication, homeostasis, and cellular waste disposal (32, 35). Apoptotic bodies represent particles ranging
from 50 nm to 5 m, which are released by apoptotic cells and
removed through phagocytosis by macrophages (32, 34). Given
that the level of MVs is elevated in the body fluids of humans
afflicted with various ailments, some authors have proposed
that these vesicles may play a role in disease conditions that
include arthritis, atherosclerosis, cancer, and chronic kidney
disease (31, 36, 37). On the other hand, it remains unclear
whether MVs represent a consequence of the disease process or
whether they play an active role in pathogenesis.
Matrix vesicles represent a different type of extracellular
vesicles implicated in physiological and pathological calcification processes in vertebrates (38 – 40). Matrix vesicles are
20 –200-nm vesicles released from mineralizing cells, such as
osteoblasts and odontoblasts, which induce mineralization in
bones and teeth, respectively. During ectopic vascular calcification, these vesicles are also released by vascular smooth muscle
cells (VSMCs), which develop into osteoblast-like cells and
induce calcium phosphate precipitation when exposed to
excess phosphate, inflammation, or hyperlipidemia (38 – 40).
Matrix vesicles are thought to induce mineralization by concentrating calcium and phosphate ions in various ways, including via
specific ion transporters; in addition, these vesicles contain
enzymes, such as alkaline phosphatase (ALP), which degrades calcification inhibitors (e.g. pyrophosphate) and releases phosphate
from various organic molecules. Although MVs similar to
matrix vesicles and apoptotic bodies have been repeatedly
described in calcified tissues (30, 41), the possibility that such
vesicles may induce the formation of mineralo-organic NPs in
body fluids has not been investigated.
Phosphatidylserine (PS), a phospholipid usually confined to
the inner lipid layer of the cell membrane (42), has been found
on the surface of various populations of MVs (32, 40). When
present on platelet-derived microvesicles, PS induces blood
coagulation, a phenomenon associated with an increased risk of
thrombosis (42, 43). On the surface of apoptotic bodies, PS is
thought to represent a signal that induces phagocytosis and
clearance of the vesicles by macrophages (42). Notably, PS possesses calcium-binding properties and may provide a nucleating site for calcium phosphate formation on both matrix vesicles (38 – 40) and apoptotic bodies (44). Whether PS found on
the surface of MVs may induce the mineralization of MVs in
body fluids remains to be examined.
Several studies have been conducted to identify the factors
that induce formation of the so-called NB and mineralo-organic NPs. Cisar et al. (18) observed that the cell membrane
lipid phosphatidylinositol produces mineral NPs similar to NB
after inoculation in DMEM and incubation in cell culture con-
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gation at 200,000 ⫻ g. Fluorescence emission was measured at
535 nm following excitation at 485 nm.
Sucrose Gradient Centrifugation—MV preparations obtained
by ultracentrifugation were diluted to 10% (v/v) in 1 ml of HEPES
buffer and layered on top of a centrifugation tube (Ultra-Clear
centrifugation tubes, 14 ⫻ 89 mm, Beckman Instruments) containing a linear sucrose gradient (0.2–20% sucrose, 20 mM
HEPES, pH 7.4) prepared using a gradient maker (Gradient
Station, BioComp Instruments). After centrifugation at
100,000 ⫻ g for 15 h at 4 °C, 1-ml fractions were collected from
the top of the tube. Collected fractions were dialyzed using a
commercial microdialysis system (Invitrogen) using a membrane with a 12–14-kDa cut-off (Spectra).
Lipid Analysis—Lipids were quantified in sucrose gradient
fractions by using commercial kits for phospholipids (BioAssay
Systems), cholesterol, triglycerides, HDL, and LDL (BioVision)
based on the manufacturer’s instructions.
Western Blotting—SDS-PAGE and Western blot analysis
were performed as before (9). A fraction of MVs corresponding
to 60 g of MV proteins, 60 g of proteins from mineraloorganic NPs seeded by MVs, or 60 g of proteins from either
HeLa cells or whole serum was dissolved in 5⫻ “loading buffer”
(0.313 M Tris-HCl, pH 6.8, 10% SDS, 0.05% bromophenol blue,
50% glycerol, 12.5% ␤-mercaptoethanol) to a final concentration of 1⫻, prior to heating at 95 °C for 5 min and separation
under denaturing and reducing conditions on 10% SDS-PAGE
using a minigel system (Hoefer). HeLa cells were purchased
from the ATCC and cultured in minimum essential medium
containing 10% FBS and 100 units/ml of both penicillin and
streptomycin. The primary antibodies used were goat polyclonal anti-tissue nonspecific ALP (sc-15065, Santa Cruz
Biotechnology), mouse monoclonal anti-LAMP2 (lysosomeassociated membrane protein 2) (sc-18822), goat polyclonal
anti-human TNFR1 (tumor necrosis factor receptor 1) (sc31349), rabbit polyclonal anti-annexin V (sc-8300), goat polyclonal anti-CD63 (cluster of differentiation 63) (sc-31214), and
rabbit polyclonal antibodies prepared in-house as described
below. The secondary antibodies used were horseradish peroxidase-conjugated anti-goat, anti-mouse, anti-sheep, or antirabbit antibodies (Santa Cruz Biotechnology). Primary and secondary antibodies were diluted based on the instructions
provided by the manufacturer. The polyclonal antibodies generated in house were used at a dilution of 1:1,000. The blots
were revealed using enhanced chemiluminescence (Amersham
Biosciences) and autoradiographic films (Molecular Technologies). Membranes were stripped by using the ReBlot Western
blot recycling kit (Chemicon).
Production of Polyclonal Antibodies—New Zealand White
rabbits were obtained at ⬃12 weeks of age. Human serum albumin, human serum fetuin-A, and human apolipoprotein AI
(apoA-I) as well as bovine serum fetuin-A and bovine serum
albumin were purchased from Sigma. The purified proteins
(500 g) were dissolved in 1 ml of DMEM and mixed with 1 ml
of Freund’s complete adjuvant (Sigma) using two syringes connected by a 3-way stopcock (Nipro). Each protein-adjuvant
mixture was administered intradermally on the back of the animals. Three weeks after the first immunization, one booster
dose (200 g of protein in a 1:1 mixture of DMEM and incomJOURNAL OF BIOLOGICAL CHEMISTRY
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Optical and Electron Microscopies—Aliquots of MVs resuspended in HEPES buffer were deposited on glass slides and
observed without fixation or staining with a BX-51 optical
microscope (Olympus) equipped with a ⫻100 oil immersion
objective with iris (UPlanFLN, Olympus) and a dark field condenser (Cerbe Distribution). Specimens were observed at a
magnification of ⫻1,000, and images were acquired with a Spot
Flex color camera (Diagnostic Instruments).
For negative stain TEM, MV preparations were deposited
onto Formvar carbon-coated grids and negatively stained with
0.5% aqueous uranyl acetate, followed by drying overnight at
room temperature. In some experiments, MVs were treated
with 0.1% (v/v) Triton X-100 prior to processing for negative
staining. Specimens were examined under an EMU-3C (RCA)
or JEM-100B (JEOL) transmission electron microscope.
Precipitates obtained following incubation of DMEM containing MVs (with or without added serum) were pelleted by
centrifugation at 12,000 ⫻ g for 15 min and washed twice with
HEPES buffer prior to resuspension in the same buffer. A small
aliquot was deposited onto carbon-coated grids before drying
overnight. In this case, the particles were observed without fixation or staining by TEM. Electron diffraction patterns were
obtained with the JEM-100B transmission electron microscope
operated at 120 keV.
For immunogold staining, MVs were deposited onto nickel
grids and blocked with PBS plus 1% gelatin. The grids were
placed on liquid drops containing the diluted protein or antibody for 1 h at room temperature. MVs were treated successively with annexin V (BD Biosciences), rabbit polyclonal antiannexin V antibody (sc-8300, Santa Cruz Biotechnology, Inc.),
and goat anti-rabbit antibody conjugated with a 5-nm gold NP
(R-14001, Agar Scientific). Between each treatment, MVs were
washed successively with PBST, 0.1% Tween 20 in PBS (5 min).
Fluorescence Spectroscopy—MVs were quantified as before
(49, 50) by measuring the concentration of total proteins using
a commercial Bradford protein assay (Bio-Rad). To detect lipid
membranes, we mixed a fraction of MVs corresponding to 0.5
g of MV proteins with 0.1 mM 1,1⬘-dioctadecyl-3,3,3⬘,3⬘tetramethylindotricarbocyanine iodide (DiR; Molecular Probes)
in a final volume of 1 ml. The probe was initially dissolved in
0.5% ethanol. Specimens were incubated for 1 h at room temperature with continuous agitation. The same amount of lipophilic tracer was added to HEPES buffer and processed in the
same manner as a negative control. THP-1 cells (2 ⫻ 104 cells/
ml) purchased from the American Type Culture Collection
(ATCC) were used as a positive control. These cells were maintained in RPMI 1640 medium containing 10% FBS and 100
units/ml of both penicillin and streptomycin. Fluorescence was
measured using a fluorescence microplate reader (Spectra Max
M5 Spectrophotometer, Molecular Devices) with excitation at
748 nm and emission at 780 nm.
To detect PS on the surface of MVs, we mixed 5 l of FITClabeled annexin V (BD Biosciences) with a MV fraction corresponding to 30 g of total MV proteins dissolved in 100 l of
HEPES buffer (containing 2.5 mM CaCl2), with or without 0.5
mM EDTA. Reaction mixtures were incubated for 30 min at
room temperature and subsequently washed with HEPES
buffer to remove unbound annexin V following ultracentrifu-
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12,000 ⫻ g for 30 min and washed twice with HEPES buffer
prior to resuspension in water. Mineralo-organic NPs were
dried overnight, and EDX spectra were acquired with an SEM
S-3000N scanning electron microscope (Hitachi Science Systems) equipped with an EMAX Energy EX-400 EDX device
(Horiba).
Fourier transform infrared spectroscopy (FTIR) was performed as before (11). Briefly, the spectra were acquired using a
Nicolet 5700 FTIR spectrometer (Thermo Fisher Scientific)
equipped with a deuterated triglycine sulfate detector. Mineralo-organic NPs were prepared by adding 1 mM CaCl2 and
NaH2PO4 each in 5% FBS, followed by incubation for 1 week in
cell culture conditions (Fig. 4D, FBS-NPs). The particles were
collected by centrifugation at 12,000 ⫻ g for 15 min and washed
twice with HEPES buffer prior to drying overnight at room temperature. Commercial CaCO3 (Mallinckrodt Baker), Ca3(PO4)2
tribasic (Kanto Chemical) and HAP (buffered aqueous suspension,
25% solid; Sigma) were used for comparison.
Statistical Analysis—All experiments were performed in
triplicate. The values shown represent means ⫾ S.E. Comparisons between control and experimental groups were performed
using Student’s t test.

RESULTS
Isolation of Lipid-containing MVs from Serum—Mineraloorganic NPs initially described as NB have been shown to form
when serum or other body fluids are inoculated into a cell culture medium and incubated in culture conditions for several
days (4, 5). In contrast, incubation of the cell culture medium
alone failed to produce mineral NPs, suggesting that nucleating
agents exist in serum and body fluids. To verify whether MVs
may represent a nucleating agent that induces the formation of
mineralo-organic NPs in body fluids, we first isolated MVs
from serum using an established protocol (see “Materials and
Methods”). We hypothesized that MVs may induce mineral
nucleation on their surface and thus become the core of mineralo-organic NPs. Given that mineralo-organic NPs and the socalled NB have sizes ranging from 50 to 500 nm (5, 9), we
focused our attention on the smallest MVs present in body fluids and used a protocol involving ultracentrifugation to obtain
vesicles with diameters below 100 nm.
After ultracentrifugation of serum, we obtained a pellet containing small, round particles of variable sizes when observed
under optical, dark field microscopy (Fig. 1, A and B, insets).
Based on dynamic light scattering analysis, the particles derived
from HS showed a peak size of 37 ⫾ 14 nm, whereas the particles obtained from FBS peaked at 28 ⫾ 3 nm (Fig. 1, A and B).
The sizes of the particles obtained were relatively heterogeneous; polydispersity index values of 0.29 and 0.22 were obtained
for HS-MVs and FBS-MVs, respectively, indicating that the
sizes of HS particles were more heterogeneous than for FBS
particles.
Under negative stain TEM, MV preparations consisted of
round particles with sizes ranging from 20 to 400 nm (Fig. 1C,
Control). In order to determine whether these particles were
delineated by a lipid membrane, we treated the MV preparations with Triton X-100, a non-ionic detergent with lipid-dispersing properties (48, 51). This treatment destroyed the
VOLUME 288 • NUMBER 42 • OCTOBER 18, 2013
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plete Freund’s adjuvant; Sigma) was administered every month
for a total of four times. Pre- and postimmunization blood was
collected from the ear vein. For apoA-I, 28 –30 kDa gel bands
corresponding to ⬃200 g of protein from SDS-PAGE bands of
whole serum were used for the immunizations as described
above.
Seeding of Mineralo-organic NPs by MVs—MVs obtained by
either ultracentrifugation or sucrose gradient centrifugation
were added into DMEM with or without 10% serum to obtain a
final volume of 1 ml. The 24-well plates were incubated under
cell culture conditions in a humidified cell culture incubator at
37 °C with 5% CO2. Photography of the plates and A650 readings
were performed as before (9). Day 0 pictures and turbidity
measurements were taken after reagent mixing. Mineralo-organic NPs obtained after incubation were pelleted by centrifugation at 12,000 ⫻ g for 30 min and washed twice with HEPES
buffer prior to resuspension in the same buffer for further morphological and spectroscopy analyses.
Calcium Deposition Assay—The ability of MVs to calcify was
assessed using a non-radioactive calcium phosphate deposition
assay (49). Briefly, phospholipid-rich MV fractions corresponding to 30 g of total MV proteins were added into DMEM and
incubated in cell culture conditions. The incubation was terminated at each time point by centrifugation at 12,000 ⫻ g for 30
min to obtain a co-precipitate of MVs and mineralo-organic
NPs. The mineral precipitate was solubilized in 0.6 M HCl for
24 h. The calcium content of the HCl supernatant was then
determined colorimetrically by using the O-cresolphthalein
complexone method (BioVision). Briefly, 2 l of acidified
supernatant was incubated for 1 min with 150 l of calcium
working reagent (chromogenic ⫹ base reagent mix) prior to
measurement with a microplate spectrophotometer. Absorbance was read against a blank at 575 nm within 10 min of reagent mixing.
To evaluate the contribution of PS to mineral seeding, we
mixed MVs (2 mg of total proteins) with 0.2 g of either anti-PS
or anti-CD63 antibody in a final volume of 1 ml of HEPES buffer
and incubated the resulting solution for 1 h at room temperature with gentle mixing. MVs were pelleted and washed following ultracentrifugation at 200,000 ⫻ g for 2 h at 4 °C. MVs were
resuspended and incubated in 1 ml of DMEM in cell culture
conditions. After 1 week of incubation, mineral pellets were
retrieved and washed using centrifugation at 12,000 ⫻ g for 15
min. The calcium deposition assay was used to measure the
level of mineral precipitate formed.
MV Co-Precipitation Assay—A MV fraction corresponding
to 30 g of MV proteins was added into DMEM prior to the
addition of 0.1–3 mM CaCl2 and NaH2PO4 each. After incubation in cell culture conditions for 24 h, the precipitate was harvested by centrifugation at 12,000 ⫻ g for 30 min. After washing
in HEPES buffer, the precipitate was resuspended in 50 l of
HEPES buffer and subjected to SDS-PAGE and Western blotting with the indicated antibodies. Samples that were not incubated were used in parallel for comparison.
Spectroscopy Analyses—Energy-dispersive x-ray spectroscopy (EDX) was performed as described previously (10). Briefly,
material obtained after incubation of DMEM containing MVs
(with or without serum) was pelleted by centrifugation at
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integrity of serum-derived particles, leaving only membrane
remnants (Fig. 1C, Triton X-100). To confirm these observations, we used the lipophilic tracer DiR, which is weakly fluorescent in an aqueous environment but becomes highly fluorescent when intercalated within a lipid membrane. Accordingly,
DiR did not fluoresce in HEPES buffer used as a negative control but produced fluorescence when incubated with human
acute monocytic leukemia THP-1 cells used as a positive control (Fig. 1D). DiR treatment also produced fluorescence in the
presence of MVs obtained from either HS or FBS (Fig. 1D),
confirming that the isolated MVs were lipid-bound vesicles.
Biochemical Characterization of Serum-derived MVs—Next,
we fractionated the MV preparations by sucrose gradient centrifugation and determined the biochemical composition of
each 1-ml fraction. The concentration of phospholipids, cholesterol, triglycerides, and lipoproteins (i.e. LDL and HDL) in
each fraction was determined using standardized biochemical
assays. Our results showed that MV fractions contained relatively high concentrations of phospholipids, averaging from 30
to 93 M for HS-derived vesicles (Fig. 2A) and from 4 to 15 M
for FBS-derived vesicles (Fig. 2B). Cholesterol was detected in
low amounts in HS-derived MVs (Fig. 2A, fractions 4 – 6, peak
at 2 M), but none was found in FBS-MVs (Fig. 2B). Triglycerides, LDL, and HDL were not detected in the MV fractions
tested (Fig. 2, A and B; data not shown), indicating that the
isolated MV fractions did not contain lipoproteins.
We then performed Western blot analysis to examine the
proteins associated with serum-derived MVs. We found that
ALP, a glycosylated membrane-bound enzyme associated with
OCTOBER 18, 2013 • VOLUME 288 • NUMBER 42

biomineralization processes (52, 53), was associated with the
phospholipid-rich MV fractions (Fig. 2, C and D). The molecular weight of the ALP found in HS-MVs (55 kDa) was smaller
than the one found in FBS-MVs (72 kDa), possibly indicating
the presence of different ALP isoenzymes in these samples. We
also detected the presence of the exosome-associated proteins
TNFR1 and CD63 in phospholipid-rich fractions (Fig. 2, C and
D), whereas other exosome proteins like LAMP2 were not
detected in our specimens (data not shown).
Albumin, fetuin-A, and apoA-I were also found in association with serum-derived MVs (Fig. 2, C and D). Although
fetuin-A and apoA-I were associated with fractions of lighter
densities compared with fractions containing exosome proteins, the three serum proteins overlapped to some extent with
exosome-associated proteins. These serum proteins have been
consistently associated with mineralo-organic NPs derived
from body fluids, and they have been shown to act as both
inhibitors and seeders of mineral particles in culture (9 –11).
The structural and morphological data reported here along
with the co-distribution of phospholipids and exosome proteins confirmed that the particles isolated from serum consisted of MVs and included exosomes. Given that the sizes of
the isolated MVs (20 – 400 nm) exceeded the sizes reported
previously for exosomes (30 –100 nm) (32–34), we concluded
that other vesicles, possibly microvesicles and apoptotic bodies,
may also be present in our MV preparations.
Serum-derived MVs Induce Mineral Precipitation in Culture—
To determine whether serum MVs may induce the formation of
mineralo-organic NPs and mineral precipitation in body fluids,
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. Characterization of serum MVs isolated by ultracentrifugation. MVs were isolated from HS (A) and FBS (B) by ultracentrifugation as described
under “Materials and Methods.” Round particles of heterogeneous sizes were observed under optical, dark field microscopy without fixation or staining
(insets, ⫻1,000). Particle sizes measured by dynamic light scattering peaked at 37 ⫾ 14 nm for HS and 28 ⫾ 3 nm for FBS. C, negative stain TEM revealed round,
20 –500-nm structures (Control) susceptible to treatment with a lipid-dispersing detergent (Triton X-100; 0.1%, v/v). D, treatment with a fluorescent, lipophilic
probe (DiR; 0.1 mM) showed that both HS-MVs and FBS-MVs (corresponding to 0.5 g of total MV proteins) produced fluorescence and thus harbored a lipid
membrane. As controls, DiR produced no fluorescence in HEPES buffer but fluoresced when incorporated in cell membranes (THP-1; 2 ⫻ 104 cells/ml). *, p ⬍
0.01 versus control HEPES. Error bars, S.E.
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we inoculated MVs into DMEM and incubated the resulting
mixture in cell culture conditions for several days (Fig. 3A).
Although the addition of MVs into DMEM produced no turbidity following inoculation at day 0, precipitation visible to the
naked eye was observed in most wells containing MVs after 1
week of incubation (Fig. 3A). The precipitation increased in a
dose-dependent manner with the amount of MVs added and
was more abundant for FBS-MVs than for HS-MVs. The level
of visible precipitation continued to gradually increase with
time, as seen after 2 weeks of incubation (Fig. 3A, 1 Week versus
2 Weeks). The observations of visible MV-induced precipitation were consistent with the turbidity increase monitored by
spectrophotometry at a wavelength of 650 nm (Fig. 3A, A650).
To confirm that serum MVs induce the formation of mineral
precipitates in culture, we used another assay that monitors calcium deposition in a non-radioactive manner. We noticed that
DMEM containing MVs showed a time-dependent increase in calcium deposition during incubation, whereas no calcification was
observed in DMEM alone (Fig. 3B). As seen earlier (Fig. 3A), precipitation levels produced by FBS-MVs were slightly higher than
those produced by HS-MVs (Fig. 3B).
To identify the biochemical component of MV fractions that
induces mineral precipitation, we inoculated MV fractions
obtained by sucrose gradient centrifugation into DMEM and
measured the level of mineral precipitation following incubation in different cell culture conditions. After 2 months of incubation, the MV fractions containing high levels of phospholipids
induced higher levels of mineral precipitation than MV fractions containing low amounts of phospholipids (Fig. 3C). Similar results were obtained for incubation periods of either 2
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weeks or 1 month (data not shown). These results indicate that
phospholipid-rich MV fractions induce mineral precipitation
in culture.
In order to evaluate whether MVs induce mineral precipitation by binding to calcium and phosphate ions in cell culture
medium, we inoculated MVs into DMEM and treated the
resulting mixture with calcium and phosphate ions to induce
mineral precipitation. We have shown previously (9 –11) that
the addition of calcium and phosphate ions in DMEM containing a body fluid produces mineral precipitates without the delay
usually required for mineral NPs to spontaneously form in culture. Here, a constant amount of MVs was added into DMEM,
followed by the addition of calcium and phosphate ions at 0.1–3
mM each. After overnight incubation in cell culture conditions,
the precipitates were harvested by centrifugation and subjected
to Western blot analysis to detect MV proteins (Fig. 3, D and E).
Whole HS used as a control showed the presence of the proteins ALP (low signal), TNFR1, and CD63 as well as albumin,
fetuin-A, and apoA-I (Fig. 3D, lane 1). In the case of whole FBS,
all of these proteins were detected (Fig. 3E, lane 1). As shown
earlier in Fig. 2, C and D, HS-MVs and FBS-MVs harbored ALP,
TNFR1, CD63, albumin, fetuin-A, and apoA-I (Fig. 3, D and E,
lane 2). When MVs were added into DMEM and centrifuged at
low speed (12,000 ⫻ g), the vesicles could not be pelleted, as
seen by the absence of MV-associated proteins in this control
experiment (Fig. 3, D and E, lane 3). However, after inoculation
of MVs into DMEM and incubation for 1 day in cell culture
conditions prior to low speed centrifugation, several MV proteins were detected (Fig. 3, D and E, lane 4), suggesting that
MVs induced the formation of mineral precipitate following
VOLUME 288 • NUMBER 42 • OCTOBER 18, 2013
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FIGURE 2. Biochemical characterization of serum-derived MVs. A and B, lipid characterization of serum MVs. MVs isolated by ultracentrifugation as in Fig. 1
were further fractionated by sucrose gradient centrifugation as described under “Materials and Methods.” The phospholipid, cholesterol, and triglyceride
content of each 1-ml fraction were assessed using standardized biochemical assays. C and D, protein characterization of serum MVs. Proteins from individual
MV fraction corresponding to 60 g of total proteins were separated by SDS-PAGE under denaturing and reducing conditions and analyzed by Western
blotting with the indicated antibodies. The blots shown here were assembled from two different gels run in parallel, and they are separated by a blank space
between fractions 9 and 10.
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FIGURE 3. Serum MVs induce mineral precipitation in cell culture conditions. A, MVs prepared by ultracentrifugation from HS and FBS were quantified based on
total protein content prior to inoculation into DMEM at the amount indicated (Day 0, final volume of 1 ml). The solutions were incubated in cell culture conditions for
the time indicated. MVs produced visible precipitation that increased in a time-dependent manner. DMEM used as a negative control produced no precipitation. B, the
ability of MVs isolated by sucrose gradient centrifugation to undergo calcification. Phospholipid-rich MV fractions corresponding to 30 g of total protein were added
into DMEM and incubated in cell culture conditions. Precipitates were collected at the time indicated following centrifugation at 12,000 ⫻ g for 30 min, and the calcium
content was determined using the O-cresolphthalein complexone assay. Both HS-MVs and FBS-MVs induced the formation of calcified precipitate in a time-dependent manner during incubation. C, phospholipid-rich MV fractions induce mineral precipitation in culture. 100 l of each sucrose gradient fraction was added into
DMEM in a final volume of 1 ml prior to incubation in cell culture conditions for 2 months. Mineral precipitation was assessed by A650 turbidity readings. Turbidity
observed before incubation was subtracted from the turbidity reading obtained after incubation (Differential A650). The content of phospholipids was determined
using a standardized biochemical assay. Phospholipid-rich fractions produced slightly higher levels of precipitation under these conditions. D and E, Western blotting
analysis of co-precipitates containing MVs and mineralo-organic NPs. MVs were inoculated into DMEM, and CaCl2 and NaH2PO4 were added at the concentration
indicated in a final volume of 1 ml prior to incubation in cell culture conditions for 1 day. Mineral precipitates were pelleted by centrifugation at 12,000 ⫻ g for 30 min
prior to washing steps in HEPES buffer. Equal amounts (60 g) of proteins from whole serum, MVs, or MV-NP co-precipitates were separated under denaturing and
reducing conditions by SDS-PAGE and probed with the indicated antibodies. Some of the lanes shown here originated from two different gels run in parallel; these are
delineated by the blank space seen in some of the blots. **, 0.1 ⬍ p ⬍ 0.5. Error bars, S.E.

incubation and that this precipitate was heavy enough to be
pelleted by the low speed centrifugation used. When HS-MVs
were incubated into DMEM with exogenous calcium and phosOCTOBER 18, 2013 • VOLUME 288 • NUMBER 42

phate ions were added at 0.1–3 mM each, MV-associated proteins were also detected, and most proteins (ALP, TNFR1,
CD63, and apoA-I) produced signals that increased in a doseJOURNAL OF BIOLOGICAL CHEMISTRY
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eralo-organic NPs observed in calcified human tissues (30, 57)
consist of carbonate HAP, a mineral similar to the one found in
bones and teeth of vertebrates (58, 59). EDX spectra of mineral
particles seeded by MVs in DMEM showed major peaks of carbon (C), calcium (Ca), oxygen (O), sodium (Na), phosphorus
(P), and sulfur (S) (Fig. 4C, HS-MVs⫹DMEM and FBSMVs⫹DMEM), consistent with the presence of carbonate-calcium phosphate in MV-seeded NPs. Similarly, the particles seeded
by MVs in DMEM containing serum showed similar peaks consistent with the formation of carbonate-calcium phosphate (Fig.
4C, HS-MVs⫹DMEM⫹HS and FBS-MVs⫹DMEM⫹FBS).
FTIR analysis revealed major peaks of phosphate at 566
cm⫺1, 604 cm⫺1, 960 cm⫺1, and 1,033–1,100 cm⫺1 in the particles seeded by MVs in DMEM with or without serum (Fig. 4D;
compare with the spectra of commercial Ca3(PO4)2 and HAP
shown for reference; see also Refs. 60 and 61). In addition, peaks
corresponding to carbonate at 875 and 1,430 cm⫺1 were found
in MV-seeded particles (Fig. 4D; compare with the signals
obtained for CaCO3; see also Refs. 62 and 63). For comparison,
a sample of mineralo-organic NPs prepared by adding calcium
and phosphate into DMEM containing 5% FBS showed similar
phosphate and carbonate peaks (Fig. 4D, FBS-NPs). These FTIR
spectra were consistent with the presence of carbonate HAP
within the MV-seeded particles. Other peaks corresponding to
H2O and the amide bonds of serum proteins were also detected
in the seeded particles (Fig. 4D; see also Refs. 58, 64, and 65).
These spectroscopy analyses confirm that the MV-seeded particles contain carbonate HAP similar to the particles described
earlier as NB (7) and to the mineralo-organic NPs found in
calcified human tissues (30).
PS on the Surface of MVs Contributes to Mineral NP Seeding—
PS appears to represent a nucleator of calcium phosphate in
matrix vesicles (38, 66). Several MV populations, such as those
released by platelets and apoptotic cells, harbor PS on their
surface (67, 68), but it is unclear whether PS acts as a nucleator
in this context. We first used Western blot analysis to examine
whether the PS-binding protein annexin V is present in serum
MV fractions. Annexin V was not detected in either HS-MVs or
FBS-MVs (Fig. 5A; a HeLa cell lysate was used as positive control). Next, we examined whether PS is present on MVs by using
immunogold labeling and annexin V as a probe. TEM images
showed that annexin V binds the surface of MVs isolated from
HS or FBS (Fig. 5B). Similarly, using fluorescence spectroscopy,
we observed that annexin V that was prelabeled with the fluorochrome FITC interacts with MVs of both human and bovine
origins. As a control, the interaction between PS and annexin V,
which requires free calcium (69), was abrogated by the addition
of the calcium chelator EDTA (Fig. 5C). These results confirm
that PS is present on the surface of MVs isolated from serum.
We investigated whether PS found on the surface of MVs
contributes to the seeding of mineralo-organic NPs by the vesicles. We incubated MVs with an anti-PS antibody and measured the seeding potential of MVs following the washing steps.
Blocking PS moieties with the antibody significantly decreased
seeding of mineral NPs by MVs, whereas an anti-CD63 antibody used as a negative control showed no effect on seeding
(Fig. 5D). These data indicate that PS contributes to the seeding
activity of MVs.
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dependent manner with the concentration of ions added (Fig.
3D, lanes 5–7), indicating that MVs interacted with the exogenous ions to produce a mineral precipitate. In the case of FBSMVs, protein signals were also detected for all MV proteins
(Fig. 3E, lanes 5–7; note that ALP, TNFR1, CD63, and apoA-I
produced signals only after the addition of ions at 3 mM).
These results suggest that the isolated serum MVs induce the
formation of calcium-containing precipitates in culture. These
MVs may induce the formation of mineral precipitates by binding to exogenous calcium and phosphate ions in cell culture
conditions.
Morphological and Mineral Characterization of Mineraloorganic NPs Seeded by MVs—To verify the nature of the precipitation induced by MVs, we submitted the precipitates
(obtained in Fig. 3A) to TEM analysis without fixation or staining. The precipitates produced following inoculation of MVs
into DMEM consisted of small, round, electron-dense particles
of sizes varying from 10 to 400 nm (Fig. 4A). The fact that these
particles could be observed without staining suggested that
they may be coated with an electron-dense material like minerals (compare the negatively stained, non-mineralized MVs
shown in Fig. 1C with the unstained, mineralized MV-seeded
particles in Fig. 4A). Mineralization of the particles was confirmed by electron diffraction analysis, which showed several
concentric rings corresponding to a polycrystalline mineral
(Fig. 4A, insets). Particles of similar size, morphology, and electron density were noted in the precipitates seeded by FBS-MVs
(Fig. 4A). We confirmed the presence of MV proteins in the
seeded mineral NPs by Western blots (Fig. 4A, right panels).
Overall, the particles seeded by MVs were similar to the particles described earlier as NB (6, 54). No mineral particles could
be pelleted by centrifugation of incubated DMEM (data not
shown), consistent with the observation that DMEM alone does
not produce mineral NPs under these conditions (4, 5).
We also inoculated MVs into DMEM containing either 5%
HS or FBS prior to incubation for 2 weeks to compare the
nature of the particles obtained with and without serum. The
mixtures of MVs, DMEM, and serum produced mineral NPs of
a crystalline nature following incubation (Fig. 4B). Accordingly,
the electron diffraction patterns of these particles (Fig. 4B,
insets) showed concentric rings that were more pronounced
than that of the particles seeded without serum (Fig. 4A, insets).
The particles obtained this way appeared larger in size compared with the particles prepared without added serum (Fig. 4B,
20 –500 nm). All of the proteins found earlier in MVs (Fig. 2, C
and D) were detected within the MV-seeded mineral NPs (Fig.
4B, right panels).
Notably, the mineral particles seeded by MVs and serum
were highly similar not only to NB (6, 54) but also to the secondary calciprotein particles (CPPs) observed by Jahnen-Dechent and colleagues in specimens obtained from patients undergoing dialysis (55) or suffering from calcifying peritonitis (27).
These observations suggest that, in addition to MVs, serum
may provide additional compounds that induce crystallization
of the mineral particles following prolonged incubation.
Next, we used EDX and FTIR spectroscopies to identify the
mineral phase associated with MV-seeded particles. Previous
studies have shown that the so-called NB (5, 56) and the min-
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FIGURE 4. MV-induced mineral precipitation represents calcium phosphate mineralo-organic NPs. A, mineral precipitates obtained from DMEM containing MVs as in Fig. 3A were harvested by centrifugation and analyzed by TEM without fixation or staining. The precipitates displayed round NPs with a dark
electron-dense structure. The polycrystalline, mineralized nature of the particles was confirmed by the concentric rings produced on electron diffraction
patterns (insets). Western blotting analysis revealed the presence of MV-associated proteins within the seeded mineralo-organic NPs (right panels). B, mineral
precipitates obtained from DMEM containing both MVs and 5% serum showed ellipsoid NPs of a polycrystalline nature (insets). MV-associated proteins were
also detected in these particles (right panels). C, EDX spectra of mineral particles seeded by MVs with or without 5% serum showed peaks corresponding to
carbon, calcium, oxygen, sodium, phosphorus, and sulfur. D, FTIR analysis revealed the presence of both phosphate groups at 566, 604, and 960 cm⫺1 and
between 1,033 and 1,100 cm⫺1 and carbonate at 875 and 1,430 cm⫺1, consistent with the presence of carbonate apatite. Peaks corresponding to water and the
amide bonds of proteins were also observed in MV-seeded particles. Mineralo-organic NPs prepared by adding 1 mM CaCl2 and NaH2PO4 each in 1 ml of DMEM
containing 5% FBS showed similar peaks (FBS-NPs). Commercial powders of Ca3(PO4)2, CaCO3, and HAP were included for comparison. WB, Western blot.

DISCUSSION
In the present study, we show that serum MVs isolated by
ultracentrifugation and sucrose gradient centrifugation induce
the formation of mineral NPs similar to the so-called NB following incubation in cell culture conditions. These results indicate that MVs may represent the long sought nucleator of minOCTOBER 18, 2013 • VOLUME 288 • NUMBER 42

eralo-organic NPs in body fluids. Moreover, these observations
support our previous studies showing that NB-like structures
represent non-living mineral NPs that possess biomimetic
properties (9, 16).
The MVs isolated from serum harbor various proteins,
including ALP, exosome markers (TNFR1 and CD63), and
JOURNAL OF BIOLOGICAL CHEMISTRY
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serum proteins (albumin, fetuin-A, and apoA-I; Fig. 6A). The
size of the isolated MVs (30 –180 nm) and the presence of exosome markers indicate that exosomes represent the major vesicles present in our preparations, consistent with previous
results obtained with a similar fractionation protocol (32).
Given that the sizes of the MVs isolated here (30 –180 nm) are
slightly larger than the sizes reported previously for exosomes
(30 –100 nm), it is possible that microvesicles and apoptotic
bodies may represent minor constituents of our MV specimens.
The minor differences in the composition of the MVs isolated
here and in previous studies may be due to the nature of the
starting material (e.g. serum versus plasma) as well as variation
in sample preparation (70), among others.
ALP, a phosphatase enzyme found on the surface of matrix
vesicles (34, 53, 71), is found in association with the serum MVs
described here. Hunter et al. (72) have observed that blocking
ALP activity with specific inhibitors considerably decreases the
formation of mineral particles from tissue homogenate culture.
These observations support the possibility that ALP may contribute to the seeding of mineralo-organic NPs in this context.
In the case of serum proteins, we proposed in a previous
study (11) that albumin and fetuin-A may initially inhibit min-
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eral particle formation but may eventually nucleate particle formation and deposition once the concentrations of calcium and
phosphate exceed saturation levels. The results obtained in the
present study appear to support this proposal, because albumin
and fetuin-A were found in association with MVs, which in turn
induced the formation of mineralo-organic NPs in culture.
The presence of PS on the surface of MVs suggests a possible
mechanism to account for the formation of mineralo-organic
NPs induced by serum MVs (Fig. 6B). PS possesses calciumbinding properties (38 – 40), and its presence on the surface of
MVs suggests that this phospholipid may serve as a binding site
for calcium and phosphate ions. Binding of calcium and phosphate on the surface of MVs may induce mineral precipitation
and lead to the formation of fully crystallized mineral particles
with time. Such mineral NPs have been shown to evolve into
mineralized biofilm-like structures, as seen previously for the
so-called NB (5) and mineralo-organic NPs (9). Notably, several
human diseases, including include cancer, diabetes, malaria,
sickle cell anemia, thalassemia, and uremia, have been associated with increased exposure of PS on MVs or cells (73), suggesting that PS may also contribute to mineral NP formation in
these conditions.
VOLUME 288 • NUMBER 42 • OCTOBER 18, 2013
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FIGURE 5. PS exposed on the surface of serum MVs contributes to seeding of mineralo-organic NPs. A, Western blotting showing the absence of annexin
V on MVs isolated from either HS or FBS by sucrose gradient centrifugation. Equal amounts of proteins (60 g) from either HeLa cell lysates (positive control),
whole serum, or MV fractions (corresponding to the same fractions as in Fig. 2) were separated under denaturing and reducing conditions on SDS-PAGE and
probed with anti-annexin V antibody. B, annexin V-immunogold labeling of serum MVs. Fixed and stained thin sections of MVs were treated sequentially with
annexin V, rabbit anti-annexin V antibody, and gold-conjugated anti-rabbit antibody prior to observation by TEM. Binding of the gold particles to MVs revealed
the presence of PS on the vesicles’ surface. C, annexin V-fluorescence labeling of serum MVs. MVs corresponding to 30 g of total protein content were
incubated for 30 min at room temperature with FITC-labeled annexin V in 100 l of HEPES buffer prior to centrifugation and washing steps. Both HS-MVs and
FBS-MVs produced fluorescence, which was abrogated by the calcium chelator EDTA (0.5 mM). Reaction mixtures containing either no reagents or FITC-annexin
V alone were processed as above and used as negative controls. D, PS contributes to MV-induced mineral seeding. MVs (2 mg of total proteins) were treated
with either anti-PS or anti-CD63 antibody (0.2 g/ml) for 1 h at room temperature. MVs were then pelleted, washed, and incubated in DMEM for 1 week before
measuring calcium deposition. ***, p ⬍ 0.01. Error bars, S.E.
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We observed that FBS-MVs possess a higher mineral seeding
ability compared with HS-MVs (Fig. 3, A and B). Fetal serum
(i.e. FBS) may represent a better pro-calcifying milieu needed
for bone and teeth formation compared with adult serum (HS).
If this is the case, FBS-MVs may show functional differences
compared with HS-MVs; accordingly, ALP appears to be present in slightly higher amounts in FBS-MVs compared with HSMVs (Figs. 2 (C and D) and 4 (A and B)), an observation that
may partially explain the difference in seeding ability of these
vesicles.
Our results may have important implications for the understanding of ectopic calcification in humans. For one, MVs may
induce the formation of mineral NPs in tissues and body fluids
under certain conditions. Although the exact nature of these
circumstances has not been examined in the present study, various conditions could possibly induce MV-mediated seeding of
mineral NPs in vivo. For instance, a decrease in the level of
calcification inhibition proteins, an increase of calcium and
phosphate concentrations due to kidney failure, a disturbance
of vitamin D physiological activity, or an increase in the production of MVs due to inflammation or hyperlipidemia may
OCTOBER 18, 2013 • VOLUME 288 • NUMBER 42

lead to MV-induced formation of mineral NPs. In addition,
given that MVs are present in most body fluids, it appears plausible that these entities may induce the formation of mineraloorganic NPs in other areas of the body. Further studies are
currently under way to assess the relevance of MV-induced
ectopic calcification in vivo.
A prominent factor that may induce the formation of MVs
and ectopic calcification in vivo is inflammation (40). Chronic
inflammation can induce the differentiation of VSMCs into
osteoblast-like cells that produce matrix vesicles, which in turn
induce ectopic calcification. A recent study by Aikawa et al. (74)
has shown that inflammation precedes ectopic calcification in a
mouse apolipoprotein E-deficient model of atherosclerosis,
suggesting that inflammation may lead to ectopic calcification.
These authors concluded that macrophages infiltrating the
sites of lipid accumulation secrete cytokines that induce the
phenotypic differentiation of VSMCs into functional osteoblast-like cells. Given that calcium phosphate displays pro-inflammatory properties (75–77), Shanahan (78) suggested that
these processes may lead to a vicious cycle of inflammation and
calcification, which would eventually propitiate atheroscleroJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Schematic model illustrating the composition of MVs and the seeding of mineralo-organic NPs by MVs. A, illustration representing an MV
isolated from serum in the present study. Our results indicate that the isolated MVs consist of phospholipid-bound vesicles containing ALP, TNFR1, CD63,
albumin, fetuin-A, and apoA-I. PS was found in the outer phospholipid layer of MVs. B, calcium ions present in cell culture medium and body fluids may bind to
PS exposed on the surface of MVs and induce mineral precipitation. With time, mineralization of MVs may further increase and lead to the formation of fully
mineralized mineralo-organic NPs similar to the so-called NB. Molecules present in serum and body fluids may promote the crystallization of the mineral
particles and produce mineral precipitates similar to those observed previously in human calcified tissues.
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Note Added in Proof—We have recently extended the findings on
calcium apatite nanoparticles to other types of cations which also
assemble nano- and micro-scale structures resembling biological
topologies, which we have termed collectively as bions (Wu, C. Y.,
Young, L., Young, D., Martel, J., Young, J. D. (2013) Bions: A family of
biomimetic mineralo-organic complexes derived from biological
fluids. PLoS One 8, e75501).
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sis. We recently found that mineralo-organic NPs of calcium
phosphate do not activate pro-inflammatory reactions in
macrophages but that large particle aggregates led to caspase-1
activation and secretion of pro-inflammatory IL-1␤ (17). These
results suggest that mineral NPs nucleated by MVs may initially
be inert in the body but may eventually induce inflammation
and participate in disease processes after reaching a certain size.
Apoptosis represents another factor that may control the
formation of mineral NPs and ectopic calcification in the body.
A previous study by Proudfoot et al. (44) showed that VSMCs
calcify after about 28 days in culture and that apoptosis appears
prior to mineral precipitation. Blocking apoptosis with a pancaspase inhibitor reduced calcification, whereas induction of
apoptosis with anti-Fas IgM increased calcification in culture.
In the end, calcification was attributed to the release of apoptotic bodies (44) similar to the MVs studied here.
Obviously, differences may exist between the in vitro system
studied here and what might occur in the human body. For
instance, the observation that PS is exposed on the surface of
MVs suggests that these MVs could be subject to constant
phagocytosis and clearance by macrophages of the reticuloendothelial system in vivo. It remains to be seen under what conditions procalcifying MVs similar to the ones characterized
here may accumulate at amounts high enough in body fluids to
induce the formation of mineralo-organic NPs and larger calcified deposits.
Jahnen-Dechent and colleagues (79, 80) have proposed that
mineral NPs in the form of CPPs may be part of a larger physiological cycle that controls the use and clearance of mineral
ions in the body. These authors have proposed that serum proteins like fetuin-A may serve as systemic calcification inhibitors
and chaperone molecules that stabilize excess calcium and
phosphate in the form of CPPs, leading to clearance of the particles by the reticuloendothelial system (81). Recently, these
authors have shown that the scavenger receptor-A present on
macrophages is implicated in the recognition and rapid clearance of CPPs from the blood of mice (82).
From another perspective, we noticed that the MVs isolated
from serum (Fig. 1, A and B) share similarities with a group of
intriguing particles described previously in the blood under
various names, including “microzymas,” “protits,” “somatids,”
“cancer bacteria,” “pleomorphic bacteria,” and “filterable bodies,” among other terms (83– 86). Vodyanoy and colleagues (87)
have reported that metal nanoclusters may form structures
referred to as “proteons” when they bind to denatured proteins
in various body fluids, such as blood. Based on these and similar
observations (8 –17), we believe that the putative microzymas,
protits, somatids, and related entities may represent a combination of various particles that form spontaneously in the blood
during incubation, which may include MVs, mineralo-organic
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